Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11932625 Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Nicholas Paul Kwiatkowski0

Baishan Jiang0

Tinghu Zhang0

Nathanael S. Gray0

Date of Patent

March 19, 2024

0

Patent Application Number

176888220

Date Filed

March 7, 2022

0

Patent Citations

US Patent 10969394 Reagents and methods for analysis of proteins and metabolites targeted by covalent probes

0

US Patent 11306070 Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof

0

US Patent 11040957 Heteroaromatic compounds useful for the treatment of proliferative diseases

0

US Patent 11325910 Inhibitors of cyclin-dependent kinases

0

US Patent 10047070 Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

0

US Patent 10906889 Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

0

Patent Primary Examiner

Daniel R Carcanague

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11932625 Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool